Search Results - "Mandac, Inga"

Primary Bone Lymphoma of the Scapula by Lovaković, Josip, Mandac Smoljanović, Inga, Matković, Andro, Smoljanović, Tomislav

“…Primary bone lymphoma of the scapula is a rare tumor that usually causes local pain. The presented patient suffered for two years from paresthesia, tingling,…”
Get full text

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective by De Witte, Theo, Malcovati, Luca, Fenaux, Pierre, Bowen, David, Symeonidis, Argiris, Mittelman, Moshe, Stauder, Reinhard, Sanz, Guillermo, Čermák, Jaroslav, Langemeijer, Saskia, Hellström-Lindberg, Eva, Germing, Ulrich, Skov Holm, Mette, Mądry, Krzysztof, Tatic, Aurelia, Medina Almeida, António, Savic, Aleksandar, Mandac Rogulj, Inga, Itzykson, Raphael, Hoeks, Marlijn, Gravdahl Garelius, Hege, Culligan, Dominic, Kotsianidis, Ioannis, Ades, Lionel, Van de Loosdrecht, Arjan A, Van Marrewijk, Corine, Yu, Ge, Crouch, Simon, Smith, Alex

Get full text

First-Line Therapy for Nodal T-cell Non-Hodgkin Lymphomas: an Unmet Need in Hematology by Milunović, Vibor, Smoljanović, Inga Mandac, Patekar, Martina Bogeljić, Zatezalo, Viktor, Kursar, Marin, Radić-Krišto, Delfa, Kolonić, Slobodanka Ostojić, Gašparov, Slavko

“…Purposeof Review The main aim of this review is to summarize first-line therapy of nodal T-cell non-Hodgkin lymphoma. Recent Findings Current treatment with…”
Get full text

Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience by Galunic Bilic, Lea, Santek, Fedor, Grah, Josip J., Basic-Kinda, Sandra, Mandac Smoljanovic, Inga, Ostojic Kolonic, Slobodanka, Mitrovic, Zdravko, Vodanovic, Marijo, Dujmovic, Dino, Aurer, Igor

“…Purpose Data on efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients are scarce. We therefore performed this retrospective study…”
Get full text

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow‐up for Myelodysplastic Syndromes by Loosdrecht, Arjan A., Mandac Smoljanović, Inga

Get full text

Alterations within the Osteo-Hematopoietic Niche in MDS and their Therapeutic Implications by Mies, Anna, Bulycheva, Ekaterina, Rogulj, Inga Mandac, Hofbauer, Lorenz C, Platzbecker, Uwe

“…Hematopoietic and mesenchymal stem and progenitor cells are organized in the osteo-hematopoietic niche, a complex microenvironment ensuring self-renewal and…”
Get more information

Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma: A Review by Milunović, Vibor, Hude, Ida, Rinčić, Goran, Galušić, Davor, Grubešić, Aron, Martinović, Marko, Popović, Nika, Divošević, Sunčana, Brčić, Klara, Međugorac, Marin, Kužat, Luka, Strahija, Dejan, Mrđenović, Stefan, Mandac Smoljanović, Inga, Radić-Krišto, Delfa, Gašparov, Slavko, Aurer, Igor, Ostojić Kolonić, Slobodanka

“…Elderly patients make up a significant number of cases of newly diagnosed Hodgkin lymphoma. However, unlike in young patients, the outcomes of elderly patients…”
Get full text

Is there any Role for Splenectomy in Adulthood Onset Chronic Immun e Thrombocytopenia in the Era of TPO Receptors Agonists? A Critic al Overview by Vibor, Milunovic, Rogulj, Inga Mandac, Ostojic, Slobodanka Kolonic

“…Immune thrombocytopenia (ITP) in adulthood is characterized by chronic relapsing course. Despite the efficacious first line treatment (corticosteroid,…”
Get more information

PB2327: IS THERE ANY VALUE OF GERIATRIC INDICES IN DIFFUSE LARGE B CELL LYMPHOMA OF THE ELDERLY? by Dragčević, Dora, Duić, Tihana, Bojanic, Ana, Smoljanovic, Inga Mandac, Kursar, Marin, Gašparov, Slavko, Radić‐Krišto, Delfa, Ostojić, Slobodanka Kololonić, Lucijanic, Marko, Milunovic, Vibor

Get full text

BENDAMUSTINE: AN OLD DRUG IN THE NEW ERA FOR PATIENTS WITH NON-HODGKIN LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIA by Bogeljić Patekar, Martina, Milunović, Vibor, Mišura Jakobac, Karla, Perica, Dražen, Mandac Rogulj, Inga, Kursar, Marin, Planinc-Peraica, Ana, Ostojić Kolonić, Slobodanka

“…- The aim of this review is to present data on bendamustine, a non-cross resistant alkylating agent, alone or in combination for treatment of non-Hodgkin…”
Get full text

Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins's Lymphoma Patients-A Single Centre Experience by Galunic Bilic, Lea, Santek, Fedor, Mitrovic, Zdravko, Basic-Kinda, Sandra, Dujmovic, Dino, Vodanovic, Marijo, Mandac Smoljanovic, Inga, Ostojic Kolonic, Slobodanka, Galunic Cicak, Ruzica, Aurer, Igor

“…(1) Background: This study aimed to examine the difference in efficacy and toxicity of involved-field (IFRT) and involved-site radiotherapy (ISRT) fields in…”
Get full text

Dasatinib-induced nephrotic syndrome: a case of phenoconversion by Mandac Rogulj, Inga, Matišić, Vid, Arsov, Borna, Boban, Luka, Juginović, Alen, Molnar, Vilim, Primorac, Dragan

“…We present the case of a 33-year-old chronic myeloid leukemia (CML) female patient, in whom the occurrence of nephrotic syndrome, during the treatment with…”
Get full text

FDA's and EMA's approval of brentuximab vedotin for advanced Hodgkin lymphoma: Another player in the town? by Milunović, Vibor, Mišura Jakobac, Karla, Kursar, Marin, Mandac Rogulj, Inga, Ostojić Kolonić, Slobodanka

“…ECHELON‐1 study is a randomized open‐labeled controlled trial investigating whether addition of brentuximab vedotin to chemotherapy offers benefit over the…”
Get full text

RITUXIMAB MAINTENANCE STRATEGY IN ADVANCED FOLLICULAR LYMPHOMA: FACTS AND CONTROVERSIES by Milunović, Vibor, Patekar, Martina Bogeljić, Jakubac, Karla Mišura, Rogulj, Inga Mandac, Radić-Krišto, Delfa, Planinc-Peraica, Ana, Kolonić, Slobodanka Ostojić

“…Rituximab is a chimeric monoclonal CD20 antibody used in the treatment of CD20 positive non-Hodgkin lymphomas and has revolutionized treatment approach to…”
Get full text

The role of microRNA in myelodysplastic syndromes: beyond DNA methylation and histone modification by Milunović, Vibor, Mandac Rogulj, Inga, Planinc-Peraica, Ana, Bulycheva, Ekaterina, Kolonić Ostojić, Slobodanka

“…Myelodysplastic syndromes (MDS) are heterogeneous group of hematologic disorders of mostly elderly and based on distinct clinical phenotypes. Current paradigm…”
Get full text

Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma by Mandac, Inga, Kolonic, Slobodanka Ostojic

“…A 24-year-old female patient was diagnosed with classic Hodgkin's lymphoma in clinical stage II, and combination chemotherapy followed by radiotherapy was…”
Get full text

Mitralna i trikuspidalna valvuloplastika u bolesnice s mijelodisplastičnim sindromom by Radić-Krišto, Delfa, Mandac Rogulj, Inga, Jelić-Puškarić, Biljana, Jerkić, Helena, Kaić, Gordana, Škrtić, Anita, Zatezalo, Viktor

“…Mijelodisplastični sindrom (MDS) klonska je bolest matične hematopoetske stanice, koja se očituje poremećenom proliferacijom, diferencijacijom i sazrijevanjem…”
Get full text

Bolesnik s mijelodisplastičnim sindromom u hitnoj službi by Prkačin, Ingrid, Mandac Rogulj, Inga, Mandac Bajan, Višnja, Planinc Peraica, Ana, Cavrić, Gordana, Mileta, Dean

“…Mijelodisplastični sindrom (MDS) grupa je klonskih mijeloidnih poremećaja s heterogenom kliničkom slikom, a najveći broj komplikacija posljedica je citopenija…”
Get full text

Mijelodisplastični sindrom u bolesnice s neliječenom kroničnom limfoproliferativnom neoplazmom by Planinc-Peraica, Ana, Reschner, Ana, Kosanović-Bajić, Morana, Mandac Rogulj, Inga, Kaić, Gordana, Kursar, Marin, Martinović, Marko, Ostojić Kolonić, Slobodanka, Radić-Krišto, Delfa

“…U bolesnika s kroničnom limfoproliferativnom bolesti (LPB) veća je učestalost nastanka sekundarnih neoplazma. Istodobna pojava limfoproliferativne neoplazme…”
Get full text

Prognostički čimbenici u mijelodisplastičnom sindromu: iskustvo jednog centra by Milunović, Vibor, Mandac Rogulj, Inga, Perica, Dražen, Mišura Jakobac, Karla, Gredelj Šimec, Njetočka, Škrtić, Anita, Kardum-Skelin, Ika, Davidović Mrsić, Sanja, Ostojić Kolonić, Slobodanka

“…Uvod: Mijelodisplastični sindrom (MDS) jedna je od najčešćih klonskih hematoloških neoplastičnih neoplazma starije dobi karakterizirana jednom ili s više…”
Get full text